Biological and Clinical Database for Pancreatic Adenocarcinoma

Condition(s) studied

Investigational drug(s) / intervention(s)

Collection of biological samples: Collection of biological samples including whole blood, serum, plasma, saliva, DNA and RNA from tumor cells, tissue from tumor biopsies, tissue from tumor and adjacent tissue of pancreas

Study summary

BACAP is a biobank dedicated to the pancreatic adenocarcinoma funded by institut national institue du cancer (INCa) and coordinated by Dr Barbara Bournet from Toulouse hospital. This base includes clinical data and biological samples such as blood, serum, plasma, saliva, DNA and RNA from tumors cells.

The mission of this prospective project is to make available to the scientific community a clinical biological base from patients with pancreatic adenocarcinoma

Eligibility

Primary outcome measure(s)

• Constitution of a transdisciplinary biobank with collection of biological samples with DNA — Through the study completion, an average of 11 months
  The present project aims at creating, coordinating, animating a transdisciplinary multicentric national network, used to set up a clinical biological base (CBB) dedicated to the pancreatic adenocarcinoma
• Constitution of a transdisciplinary biobank with collection of biological samples without DNA — Through the study completion, an average of 11 months
  The present project aims at creating, coordinating, animating a transdisciplinary multicentric national network, used to set up a clinical biological base (CBB) dedicated to the pancreatic adenocarcinoma

Trial sites (16)

More University Hospital, Toulouse trials in France

Other trials for the same condition